Centre Hospitalier Universitaire De Saint Etienne

16 trials 7 recruiting Academic / non-commercial

Filter these 16 trials by condition, phase, country and more.

Open in Search →
16 Registered trials
7 Recruiting
5 Completed trials
1 Countries active
34 Unique IMPs
100% Results reported
Phase III: 4 Phase II: 4 Phase IV: 7 Phase I (Other): 1
100%

5 of 5 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Anorexia nervosa 1 Sepsis 1 Infective uveitis 1 IgA nephropathy 1

Top IMPs

ADALIMUMAB 3 APIXABAN 2 SODIUM CHLORIDE 2 3-AMINO-4-[2-[[METHYL((111C)METHYL)AMINO]METHYL]PHENYL]SULFANYLBENZONITRILE 1 ACENOCOUMAROL 1 ACETYLSALICYLIC ACID 1 AXICABTAGENE CILOLEUCEL 1 B/AUSTRIA/1359417/2021-LIKE STRAIN (B/SINGAPORE/WUH4618/2021), A/WISCONSIN/67/2022 (H1N1)PDM09-LIKE STRAIN (A/GEORGIA/12/2022 CVR-167), INFLUENZA A VIRUS, SUBTYPE H3N2, STRAIN A/DISTRICT OF COLUMBIA/27/2023-LIKE VIRUS A/VICTORIA/800/2024 CVR-289, LIVE 1 B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), INFLUENZA VIRUS B/AUSTRIA/1359417/2021-LIKE STRAIN (B/AUSTRIA/1359417/2021, BVR-26), INFLUENZA A/VICTORIA/4897/2022 IVR-238 (H1N1), INACTIVATED, INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED 1 B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), INFLUENZA VIRUS B/MICHIGAN/01/2021, INFLUENZA A/VICTORIA/4897/2022 IVR-238 (H1N1), INACTIVATED, INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED 1 BELANTAMAB MAFODOTIN 1 BREXUCABTAGENE AUTOLEUCEL 1

All trials

16 total

Showing 1–16 of 16 trials

← All sponsors A–Z